Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pfizer plans on switching remaining Exubera patients to developing MannKind treatment
Pfizer plans on switching remaining Exubera patients to developing MannKind treatment
Pfizer plans on switching remaining Exubera patients to developing MannKind treatment
Submitted by
admin
on September 16, 2008 - 9:40am
Source:
Yahoo/AP
Headline:
Pfizer plans on switching remaining Exubera patients to developing MannKind treatment
Do Not Allow Advertisers to Use My Personal information
